Global Ventricular Assist Devices Market: Trends, Share, Size, Growth, Opportunity and Forecasts

 

Ventricular Assist Devices Market

External devices attached to a patient's body known as ventricular assist devices aid to pump blood throughout the body. It is mostly applied to heart failure patients. It is a sophisticated machine that simulates how the heart works. Heart failure is a disorder when the heart's muscles become too frail to pump enough blood to the body. Heart failure can be brought on by a number of disorders, including diabetes, chronic renal and lung diseases, high blood pressure, faulty heart valves, abnormal heart rhythms, and heart attacks. Heart failure can be treated with medication, implantable cardiac devices (pacemakers), and heart transplantation, among other treatments. However, these methods have drawbacks that could result in progressive heart failure, increasing the need for ventricular assist devices.

The mechanical circulatory support device is another name for a Ventricular Assist Devices Market. It is a machine that aids in pumping blood from the heart's bottom chambers to the rest of the body. Ventricular Assist Devices Market come in a variety of forms, including right ventricular assist devices (RVADs), left ventricular assist devices (LVADs), and others. The most prevalent VADs are left ventricular assist devices because patients with heart disease frequently have weak left ventricle muscles. They have been employed as a long-term fix for people whose odds of improving their cardiac muscles are slim. Blood from the right ventricle is pumped to the pulmonary aorta using right ventricular assist devices (VADs). 

When the right ventricle of a patient with a significantly weak left ventricle also becomes weak, BIVAD or the addition of RVAD is used to treat the condition. The prevalence of cardiovascular illnesses is on the rise, the risk of organ failure is rising, and several prominent manufacturers are developing novel Ventricular Assist Devices Market, all of which are contributing to the market's expansion. As of June 2020, 3,582 candidates were listed on the American heart transplant waiting list, according to the Organ Procurement and Transplantation Network. As a result, the demand for ventricular assist devices has increased as the number of patients with heart failure has increased, which is expected to support the expansion of the ventricular assist devices market.

Key Players

Abiomed, Inc., Abbott Laboratories, Heart Ware International, Inc., Berlin Heart GmbH, Thoratec, Inc., Liva Nova plc, Jarvik Heart, Inc., Medtronic plc, ReliantHeart, Inc., and Calon Cardio-Technology Ltd. are important market participants for ventricular assist devices.

Comments